Several ProPhase employees will transfer to Pharmaloz, thereby reducing the Company’s overhead. Overall, the transaction better positions the Company to focus on its highly promising and high value ...
In a challenging market environment, ProPhase Labs, Inc. (PRPH) stock has touched a 52-week low, dipping to $2.02. This price level reflects a significant downturn for the company, which has seen its ...
In a challenging market environment, ProPhase Labs, Inc. (PRPH) stock has touched a 52-week low, dipping to $2.02. This price level reflects a significant downturn for the company, which has seen its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results